Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thiel

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Reproductive Health|March 4, 2018
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Reproductive Health|June 19, 2019
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed"Martin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Risk Factors for Endometriosis in a German Case-Control StudyS Burghaus, P Klingsiek, P A Fasching, et al.
Archives of Gynecology and Obstetrics|October 20, 2012
Financing of certified centers: a willingness-to-pay analysisFalk C Thiel, Anton Scharl, Thomas Hildebrandt, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
The Journal of Chemical Physics|July 3, 2024
Force Field X: A computational microscope to study genetic variation and organic crystals using theory and experimentRose A Gogal, Aaron J Nessler, Andrew C Thiel, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Reproductive Health|March 4, 2018
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView appMartin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Reproductive Health|June 19, 2019
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed"Martin C Koch, Johannes Lermann, Niels van de Roemer, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Risk Factors for Endometriosis in a German Case-Control StudyS Burghaus, P Klingsiek, P A Fasching, et al.
Archives of Gynecology and Obstetrics|October 20, 2012
Financing of certified centers: a willingness-to-pay analysisFalk C Thiel, Anton Scharl, Thomas Hildebrandt, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
The Journal of Chemical Physics|July 3, 2024
Force Field X: A computational microscope to study genetic variation and organic crystals using theory and experimentRose A Gogal, Aaron J Nessler, Andrew C Thiel, et al.
Pageof 18